Trials / Terminated
TerminatedNCT00695318
Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
A Randomized, Double-Masked, Fellow-Eye Comparison Of The Safety And Efficacy Of 0.2 And 0.5 µg/Day Fluocinolone Acetonide Intravitreal Insert To Sham Injection In Subjects With Bilateral Geographic Atrophy Due To AMD
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Alimera Sciences · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the safety and efficacy of Medidur FA treatment in one eye to the sham-treated fellow eye of subjects with geographic atrophy secondary to AMD.
Detailed description
Each patient received a sham injection in one eye and active treatment in the other eye. The eye receiving active treatment was selected based on a randomization schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluocinolone Acetonide | 0.2 µg/Day in study eye + Sham in fellow eye |
| DRUG | Fluocinolone Acetonide | 0.5 µg/Day in study eye +Sham in fellow eye |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2013-10-01
- First posted
- 2008-06-11
- Last updated
- 2015-05-29
- Results posted
- 2015-05-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00695318. Inclusion in this directory is not an endorsement.